Thyroxine modifies the effects of growth hormone in Ames dwarf mice

Aging

Volumn 7, Issue 4, 2015, Pages 241-255

  Do, Andrew ^a   Menon, Vinal ^a,b   Zhi, Xu ^a,c   Gesing, Adam ^d   Wiesenborn, Denise S ^a,e,f   Spong, Adam ^g   Sun, Liou ^g   Bartke, Andrzej ^g   Masternak, Michal M ^a,h  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

^e SAARLAND UNIVERSITY   (Germany)

^f UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

^g SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h GREATER POLAND CANCER CENTRE   (Poland)

Author keywords

Ames dwarf; Growth hormone; Insulin; Longevity; Thyroxine

Indexed keywords

GROWTH HORMONE; THYROXINE;

ANIMAL; DRUG EFFECTS; DRUG INTERACTION; DWARFISM; FEMALE; GENE EXPRESSION; LIVER; LONGEVITY; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; DRUG INTERACTIONS; DWARFISM; FEMALE; GENE EXPRESSION; GROWTH HORMONE; LIVER; LONGEVITY; MALE; MICE; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION; THYROXINE;

EID: 84929338904     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100739     Document Type: Article

References (57)

1. Bartke A, Brown-Borg H, Mattison J, Kinney B, Hauck S, Wright C. Prolonged longevity of hypopituitary dwarf mice. Experimental gerontology. 2001, 36:21-28.
2. Cheng TC, Beamer WG, Phillips JA, 3rd, Bartke A, Mallonee RL, Dowling C. Etiology of growth hormone deficiency in little, Ames, and Snell dwarf mice. Endocrinology. 1983, 113:1669-1678.
3. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature. 1996, 384:327-333.
4. Bartke A, Wright JC, Mattison JA, Ingram DK, Miller RA, Roth GS: Extending the lifespan of long-lived mice. Nature. 2001, 414:412.
5. Masternak MM, Panici JA, Bonkowski MS, Hughes LF, Bartke A: Insulin sensitivity as a key mediator of growth hormone actions on longevity. The journals of gerontology Series A, Biological sciences and medical sciences. 2009, 64:516-521.
6. Panici JA, Harper JM, Miller RA, Bartke A, Spong A, Masternak MM: Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2010, 24:5073-5079.
7. Wiesenborn DS, Ayala JE, King E, Masternak MM. Insulin sensitivity in long-living Ames dwarf mice. Age (Dordr). 2014, 36:9709.
8. Brown-Borg HM. Hormonal control of aging in rodents: the somatotropic axis. Molecular and cellular endocrinology. 2009, 299:64-71.
9. Kinney BA, Meliska CJ, Steger RW, Bartke A. Evidence that Ames dwarf mice age differently from their normal siblings in behavioral and learning and memory parameters. Horm Behav. 2001, 39:277-284.
10. Kinney-Forshee BA, Kinney NE, Steger RW, Bartke A. Could a deficiency in growth hormone signaling be beneficial to the aging brain? Physiol Behav. 2004, 80:589-594.
11. Arum O, Rasche ZA, Rickman DJ, Bartke A. Prevention of neuromusculoskeletal frailty in slow-aging ames dwarf mice: longitudinal investigation of interaction of longevity genes and caloric restriction. PLoS One. 2013, 8:e72255.
12. Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J Gerontol A Biol Sci Med Sci. 2003, 58:291-296.
13. Bartke A. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings. Aging cell. 2008, 7:285-290.
14. Dominici FP, Argentino DP, Munoz MC, Miquet JG, Sotelo AI, Turyn D. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth hormone & IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society. 2005, 15:324-336.
15. Bartke A, Westbrook R. Metabolic characteristics of longlived mice. Front Genet 2012, 3:288.
16. Brown-Borg H, Johnson WT, Rakoczy S, Romanick M. Mitochondrial oxidant generation and oxidative damage in Ames dwarf and GH transgenic mice. Journal of the American Aging Association. 2001, 24:85-96.
17. Brown-Borg HM, Bode AM, Bartke A. Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process. Endocrine. 1999, 11:41-48.
18. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996, 384:33.
19. Brown-Borg HM, Johnson WT, Rakoczy SG. Expression of oxidative phosphorylation components in mitochondria of longliving Ames dwarf mice. Age (Dordr). 2012, 34:43-57.
20. Romanick MA, Rakoczy SG, Brown-Borg HM. Long-lived Ames dwarf mouse exhibits increased antioxidant defense in skeletal muscle. Mechanisms of ageing and development. 2004, 125:269-281.
21. Kuhla A, Hahn S, Butschkau A, Lange S, Wree A, Vollmar B. Lifelong Caloric Restriction Reprograms Hepatic Fat Metabolism in Mice. The journals of gerontology Series A, Biological sciences and medical sciences. 2014; 69:915-922.
22. Mattison JA, Wright C, Bronson RT, Roth GS, Ingram DK, Bartke A. Studies of aging in ames dwarf mice: Effects of caloric restriction. Journal of the American Aging Association. 2000, 23:9-16.
23. Masternak MM, Al-Regaiey K, Bonkowski MS, Panici J, Sun L, Wang J, Przybylski GK, Bartke A. Divergent effects of caloric restriction on gene expression in normal and long-lived mice. The journals of gerontology Series A, Biological sciences and medical sciences. 2004, 59:784-788.
24. Berryman DE, Christiansen JS, Johannsson G, Thorner MO, Kopchick JJ. Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth hormone & IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society. 2008, 18:455-471.
25. Masoro EJ. Overview of caloric restriction and ageing. Mechanisms of ageing and development. 2005, 126:913-922.
26. Chen YF, Wu CY, Kao CH, Tsai TF: Longevity and lifespan control in mammals: lessons from the mouse. Ageing Res Rev. 2010, 9 Suppl 1:S28-35.
27. DeFronzo RA. Glucose intolerance and aging. Diabetes care. 1981, 4:493-501.
28. Krabbe KS, Bruunsgaard H, Hansen CM, Moller K, Fonsmark L, Qvist J, Madsen PL, Kronborg G, Andersen HO, Skinhoj P et al. Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol. 2001, 8:333-338.
29. Barbieri M, Rizzo MR, Manzella D, Grella R, Ragno E, Carbonella M, Abbatecola AM, Paolisso G. Glucose regulation and oxidative stress in healthy centenarians. Exp Gerontol. 2003, 38:137-143.
30. Paolisso G, Gambardella A, Ammendola S, D'Amore A, Balbi V, Varricchio M, D'Onofrio F. Glucose tolerance and insulin action in healty centenarians. Am J Physiol. 1996, 270:E890-894.
31. Bik W, Baranowska-Bik A, Wolinska-Witort E, Martynska L, Chmielowska M, Szybinska A, Broczek K, Baranowska B. The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinol Lett. 2006, 27:493-500.
32. Abbasi AA, Drinka PJ, Mattson DE, Rudman D: Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men. J Am Geriatr Soc. 1993, 41:975-982.
33. Milman S, Atzmon G, Huffman DM, Wan J, Crandall JP, Cohen P, Barzilai N. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging cell. 2014, 13:769-771.
34. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N, Cohen P. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci. U S A. 2008, 105:3438-3442.
35. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S et al. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. The Journal of clinical endocrinology and metabolism. 1995, 80:3209-3222.
36. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. The Journal of clinical endocrinology and metabolism. 1991, 73:1081-1088.
37. Baldelli MV, Zucchi P, Pradelli JM, Montanini V, DeSantis MC. Hormone levels in centenarians. Arch Gerontol Geriatr. 1996, 22 Suppl 1:355-362.
38. Bartke A, Chandrashekar V, Bailey B, Zaczek D, Turyn D. Consequences of growth hormone (GH) overexpression and GH resistance. Neuropeptides. 2002, 36:201-208.
39. Jadresic A, Banks LM, Child DF, Diamant L, Doyle FH, Fraser TR, Joplin GF. The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. The Quarterly journal of medicine. 1982, 51:189-204.
40. Piotrowska K, Borkowska SJ, Wiszniewska B, Laszczynska M, Sluczanowska-Glabowska S, Havens AM, Kopchick JJ, Bartke A, Taichman RS, Kucia M et al. The effect of low and high plasma levels of insulin-like growth factor-1 (IGF-1) on the morphology of major organs: studies of Laron dwarf and bovine growth hormone transgenic (bGHTg) mice. Histology and histopathology. 2013, 28:1325-1336.
41. Gesing A, Bartke A, Masternak MM. Pioglitazone does not improve insulin signaling in mice with GH over-expression. The Journal of endocrinology. 2013, 219:109-117.
42. Masternak MM, Panici JA, Wang F, Wang Z, Spong A. The effects of growth hormone (GH) treatment on GH and insulin/IGF-1 signaling in long-lived Ames dwarf mice. The journals of gerontology Series A, Biological sciences and medical sciences. 2010, 65:24-30.
43. Louis A, Bartke A, Masternak MM. Effects of growth hormone and thyroxine replacement therapy on insulin signaling in Ames dwarf mice. The journals of gerontology Series A, Biological sciences and medical sciences. 2010, 65:344-352.
44. Wang C, Li Q, Redden DT, Weindruch R, Allison DB. Statistical methods for testing effects on "maximum lifespan". Mechanisms of ageing and development. 2004, 125:629-632.
45. Wiesenborn DS, Menon V, Zhi X, Do A, Gesing A, Wang Z, Bartke A, Altomare DA, Masternak MM. The effect of calorie restriction on insulin signaling in skeletal muscle and adipose tissue of Ames dwarf mice. Aging (Albany NY). 2014, 6:900-912.
46. Panici JA, Wang F, Bonkowski MS, Spong A, Bartke A, Pawlikowska L, Kwok PY, Masternak MM. Is altered expression of hepatic insulin-related genes in growth hormone receptor knockout mice due to GH resistance or a difference in biological life spans? The journals of gerontology Series A, Biological sciences and medical sciences. 2009, 64:1126-1133.
47. Dominici FP, Argentino DP, Bartke A, Turyn D. The dwarf mutation decreases high dose insulin responses in skeletal muscle, the opposite of effects in liver. Mechanisms of ageing and development. 2003, 124:819-827.
48. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol Aging. 2005, 26:929-937.
49. Adamo ML, Neuenschwander S, LeRoith D, Roberts CT, Jr. Structure, expression, and regulation of the IGF-I gene. Adv Exp Med Biol 1993, 343:1-11.
50. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A: The somatomedin hypothesis. Endocr Rev. 2001, 22:53-74.
51. LeRoith D. Clinical relevance of systemic and local IGF-I: lessons from animal models. Pediatr Endocrinol Rev. 2008, 5 Suppl 2:739-743.
52. Yakar S, Pennisi P, Wu Y, Zhao H, LeRoith D. Clinical relevance of systemic and local IGF-I. Endocr Dev. 2005, 9:11-16.
53. Veldhuis JD. Aging and hormones of the hypothalamopituitary axis: gonadotropic axis in men and somatotropic axes in men and women. Ageing Res Rev. 2008, 7:189-208.
54. Muller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiological reviews. 1999, 79:511-607.
55. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO: Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. The Journal of clinical endocrinology and metabolism 1987, 64:51-58.
56. Painson JC, Tannenbaum GS: Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat. Endocrinology 1991, 128:2858-2866.
57. Tannenbaum GS. Somatostatin as a physiological regulator of pulsatile growth hormone secretion. Hormone research. 1988, 29:70-74.